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human galectin 1; 2D, two-dimensional; GDP, guano
molecular weight cutoff; DREAM, downstream regulat
ulator; cDNA, complementary DNA; OD, optical de
ethylenediaminetetraacetic acid; GraPES, gradient phaSmall molecules are difﬁcult to detect in protein solutions, whether they originate from elution during
afﬁnity chromatography (e.g., imidazole, lactose), buffer exchange (Tris), stabilizers (e.g., b-mercap-
toethanol, glycerol), or excess labeling reagents (ﬂuorescent reagents). Mass spectrometry and high-pres-
sure liquid chromatography (HPLC) often require substantial efforts in optimization and sample
manipulation to provide sufﬁcient sensitivity and reliability for their detection. One-dimensional (1D)
1H nuclear magnetic resonance (NMR) could, in principle, detect residual amounts of small molecules
in protein solutions down to equimolecular concentrations with the protein. However, at lower concen-
trations, the NMR signals of the contaminants can be hidden in the background spectrum of the protein.
As an alternative, the 1D diffusion difference protocol used here is feasible. It even improves the detection
level, picking up NMR signals from small-molecule contaminants at lower concentrations than the pro-
tein itself. We successfully observed 30 lM imidazole in the presence of four different proteins (1–
1.5 mg/ml, 6–66 kDa, 25–250 lM) by 1D diffusion-ordered spectroscopy (DOSY) difference and 1-h total
acquisition time. Of note, imidazole was not detected in the corresponding 1D 1H NMR spectra. This pro-
tocol can be adapted to different sample preparation procedures and NMR acquisition methods with min-
imal manipulation in either deuterated or nondeuterated buffers.
 2009 Elsevier Inc. All rights reserved.Proteins are prepared and puriﬁed by awide variety of processes.
Commonly, analyses of preparations focus on protein concentration
and activity together with purity to assess the presence of any other
proteins as a contamination. Of note, solutions can also contain low-
molecular-weight compounds whose presence may affect protein
properties and, thus, needs to be assessed. The presence of small
molecules can compromise the quality of enzyme preparations,
the accurate measurement of biophysical parameters for proteins,
the ability of a givenprotein to crystallize, or formal approval for bio-
medical application. High-pressure liquid chromatography (HPLC1),
capillary electrophoresis [1], and mass spectrometry [2] are sensitivell rights reserved.
romatography; NMR, nuclear
scopy; 1D, one-dimensional;
1B (formerly C-14); hgal-1,
sine-50-diphosphate; MWCO,
ory element antagonist mod-
nsity; UV, ultraviolet; EDTA,
se encoded spin-lock.methods to detect small-molecule contaminants. However, careful
parameter optimization is essential to adapt them to the speciﬁc
detection of distinct small molecules. Thus, it is prudent to develop
efﬁcient nondestructive assays to identify the presence of small mol-
ecules in protein-containing solutions that require no sample manip-
ulations or optimization of conditions. Here we present a nuclear
magnetic resonance (NMR)-based assay to address this issue.
Standard 1H NMR spectroscopy, if time is available for the
necessary accumulation of scans, facilitates the detection of
micromolar concentrations of low-molecular-weight compounds
(<1000 Da). However, it is inherently difﬁcult to unambiguously
distinguish these signals from the background of protein signals
at equimolar ratios of the small molecule and the protein. NMR
can exploit the different physical properties of small and large mol-
ecules, in particular those based on relaxation and diffusion. Diffu-
sion-ordered spectroscopy (DOSY) separates the NMR spectra of
molecules based on size [3–6]. Such methods are regularly used
to ﬁlter out signals from low-molecular-weight substances, in par-
ticular as a solvent suppression method [7–9]. In addition, DOSY
strategies have been implemented to detect and screen potential
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The combination of relaxation and diffusion strategies has been
shown to be effective for the removal of protein and membrane
constituent signals from plasma samples to obtain a reﬁned spec-
trum of metabolites [11]. Similar combined strategies have also
proven to be useful for the analysis of ligand-binding studies
[12,13]. None of these combined methods has been applied to
the issue of protein purity.
The current work is focused on the detection of small mole-
cules, not necessarily binders/ligands, present in protein samples
at residual or substoichiometric concentration after puriﬁcation
and/or sample preparation protocols that could contaminate and
compromise further studies with the proteins. As a consequence,
we record one one-dimensional (1D) DOSY spectrum under condi-
tions where no resonances are ﬁltered out and a second spectrum
under conditions where the small-molecule resonances are delib-
erately ﬁltered out. The difference spectrum is obtained by scaling
the two spectra, resulting in a high-quality spectrum of any small
molecules present in the solution. The protocol is of interest to all
scientists who produce protein samples, and it uses a standard
pulse program commonly distributed with Bruker instruments
that could be easily implemented for other spectrometers.Materials and methods
Materials
Aprotonin (product No. A1153), a-lactalbumin (product No.
L6010), carbonic anhydrase (product No. C3934), bovine serum
albumin (BSA, product No. A0281), imidazole, and sodium phos-
phate were purchased from Sigma–Aldrich (St. Louis, MO, USA)
and used without further manipulation. The prototype chicken
galectin 1B (CG-1B, formerly C-14) and human galectin 1 (hgal-1)
were obtained by recombinant production, puriﬁed to homogene-
ity by afﬁnity chromatography as a crucial step, and controlled for
purity by 1D and two-dimensional (2D) gel electrophoresis, gel ﬁl-
tration, and electrospray ionization mass spectrometry as well as
for activity by solid-phase and cell assays [14–18]. Lectin-contain-
ing solutions in phosphate buffer were lyophilized. Bacillus subtilis
FtsZ was expressed and puriﬁed as described previously [19,20].
Puriﬁed FtsZ was incubated on ice for 10 min with 1 mM guano-
sine-50-diphosphate (GDP) and centrifuged to remove insoluble
protein (30 min, 98,600g, 4 C) and subsequently dialyzed in a
0.25-ml unit with 4-kDa molecular weight cutoff (MWCO, G Biosci-
ences, Maryland Heights, MO, USA) against two changes of 10 mM
Tris–HCl and 50 mM KCl (pH 8.0) (2 L, 40 h) and against two
changes of 10 mM Tris–d11, 50 mM KCl (pH 7.7), and 99% 2H2O
(15 ml, 12 h). Samples were prepared in NE-HL5 NMR tubes, and
an NE-5-CIC coaxial insert was used in the indicated experiments
(New Era via Cortec, Paris, France). Deuterated materials (2H2O
and Tris–d11) were purchased from Cambridge Isotope Laborato-
ries (Andover, MA, USA).Protein expression and puriﬁcation of DREAM 71–256 and ubiquitin
Part of the human DREAM (downstream regulatory element
antagonist modulator) complementary DNA (cDNA) coding region
covering amino acids 71–256 was inserted between the NcoI/XhoI
sites of the pET28a vector, resulting in expression of His-tagged
DREAM 71–256. The DNA for His-tagged ubiquitin was synthesized
and optimized for codon use in Escherichia coli (NZYtech, Lisbon,
Portugal) and was cloned into the pET28 vector as above. Protein
expression was performed in BL21(DE) cells (NZYtech), and protein
puriﬁcation was performed according to standard protocols. The
expression of His-tagged proteins was induced with 0.5 mM iso-propyl b-d-1-thiogalactopyranoside in bacteria grown to an optical
density (OD) of 0.8, with bacteria thereafter allowed to grow for 3 h
at 30 C. Cells were collected by brief centrifugation and lysed in
binding buffer (50 mM phosphate buffer [pH 7.0] and 300 mM
NaCl) supplemented with protein inhibitors, 2.5 lg/ml DNase I,
and 0.75 mg/ml lysozyme. After lysis, the protein extract was cen-
trifuged again to separate the cell debris from soluble protein. The
obtained extract was applied to a cobalt-loaded, chelating Sephar-
ose Fast Flow column (GE Healthcare, Uppsala, Sweden). The
resulting fractions containing pure protein according to polyacryl-
amide gel electrophoresis were pooled and dialyzed extensively in
a 2.5-ml, 4-kDa MWCO unit (G Biosciences) against 800 ml of dial-
ysis buffer (10 mM phosphate and 100 mM NaCl [pH 6.8] for
DREAM 71–256 and 0.5 phosphate-buffered saline for ubiquitin)
with ﬁve changes each 8–16 h. The ﬁnal protein concentrations
were determined with Roti-NanoQuant (Carl Roth, Karlsruhe, Ger-
many) according to the manufacturer’s protocol and by ultraviolet
(UV) absorption (calculated e = 22,000 mol cm–1 at 280 nm for
DREAM and e = 1490 mol cm–1 at 280 nm for ubiquitin) as 2.0 ±
0.1 mg/ml (80 lM, DREAM) and 1.5 ± 0.3 mg/ml (160 lM, ubiqui-
tin). The dialyzed solutions of DREAM were diluted twofold with
2H2O in preparation for NMR measurements. Ubiquitin samples
consisted of 400 ll of H2O sample with 10 ll of 2H2O added for
the ﬁeld frequency lock.NMR spectroscopy
Spectra were recorded on a Bruker Avance III 500-MHz instru-
ment running TopSpin 2.1 equipped with a triple resonance TXI
probe and on a Bruker Avance II 600-MHz instrument running
XWIN-NMR equipped with a TXI cryoprobe. The p3919gp pulse
program was used to obtain 1D 1H NMR data, the stimulated echo
stebpgp1s19 pulse program was used for 2D DOSY spectra, and the
stebpgp1s191d and stebpgp1s1d pulse programs were used for 1D
DOSY spectra with and without Watergate solvent suppression,
respectively. Spectral widths of 40 ppm were set to facilitate auto-
matic baseline correction. Values of D, d, and NS are indicated in
the text and ﬁgure legends. For 1D DOSY difference, D = 100 ms,
d = 1 ms, and NS = 1024 were routinely applied parameters with
two spectra collected with gradient strengths of GPZ6 = 0% and
GPZ6 = 100% (effectively 0 and 35 G/cm for the shaped gradients
used in the pulse sequences) that were found to be optimal on the
500-MHz instrument. The two 1D DOSY spectra were processed,
phased, and baseline corrected with identical parameters. Phase
distortion of the peaks and a skewed baseline close to the residual
water signal, particularly in the GPZ6 = 0% spectrum, were reduced
by applying a digital ﬁlter according to Marion and coworkers [21]
at a cost of losing the intensity of some signals close to the water
resonance. The 100% spectrum was overlaid onto the correspond-
ing 0% spectrum. The 100% spectrum was scaled up by approxi-
mately 100% until the visible protein signals matched, and then
the difference was calculated and stored. The positive peaks in
the difference spectrum are assigned to small molecules present
in the protein solution. The 2D DOSY spectra were processed in
the corresponding two dimensions, chemical shifts (d, ppm) in
abscissas and translational diffusion coefﬁcients (D, m2 s–1) in ordi-
nates, with the DOSY module provided with the XWIN-NMR/Top-
Spin software.Results
Initial evidence for the described method emerged during the
analysis of the oligomeric state of adhesion/growth–regulatory lec-
tins (galectins) [22,23] by 2D DOSY methods and studying the ef-
fect of oligosaccharide ligands on the lectins’ quaternary
Fig. 2. Simulated plots of relative intensity versus gradient strength for three
different molecules. The traces are for water (d, D = 2  10–9 m2 s–1), a small
molecule of 100–200 Da (., D = 5  10–10 m2 s–1), and an approximately 30-kDa
protein (j, D = 1  10–10 m2 s–1). Values of D = 0.4 s and d = 4 ms were used for the
simulation.
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and lactose was routinely used to release the protein from the li-
gand-bearing resin [24]. The next step involved extensive dialysis
to remove lactose from the protein samples. The absence of char-
acteristic lactose resonances in the 3- to 4-ppm region of the 1D
1H NMR spectrum appears to conﬁrm that this molecule has been
completely removed from a solution containing CG-1B (Fig. 1A). On
inspecting the 2D DOSY spectrum of the same CG-1B-containing
sample, a series of small deﬂections became detectable toward fas-
ter diffusion in the 3- to 4-ppm range (Fig. 1B). The diffusion
dimension is processed by ﬁtting an equation that calculates the
average diffusion coefﬁcient at each position of the chemical shift.
For a pure protein, we would expect to see a straight line across the
whole spectrum because the diffusion coefﬁcient is a property of
the entire molecule. The downward deﬂections observed in
Fig. 1B are characteristic of overlapping resonances from small,
fast-diffusing molecules such as b-mercaptoethanol and Tris. How-
ever, the broader series of downward deﬂections in the 3- to 4-
ppm region is not characteristic for a simple small molecule that
contains one or two sharp resonances. In contrast, it is attributable
to the presence of lactose 1H NMR resonances (Fig. 1C). Evidently,
the 2D DOSY experiment detected a small quantity of free lactose
in the protein solution that was not tracked down in the 1D 1H
NMR spectrum. This conclusion, however, is based on our experi-
ence of acquiring DOSY data over the years and is not entirely
unambiguous. To solidify the inferred concept, we set out to devel-
op a robust and objective protocol (a concise version is available in
the Supplementary material).
Routine 2D DOSY experiments comprise a series of 32 experi-
ments over a gradient range. The change in signal intensity for
three types of molecules with different sizes over the applied gra-
dient range is simulated in Fig. 2. The ﬁrst experiment (Fig. 2, gra-Fig. 1. NMR analysis of CG-1B. (A) 1D 1H NMR spectrum of CG-1B. (B) 2D DOSY
spectrum of CG-1B. (C) 1D 1H NMR spectrum of lactose.dient = 0 G/cm) involves very little signal ﬁltering and essentially
corresponds to a normal 1D 1H spectrum. As ensuing experiments
are run, the gradient pulse providing the diffusion ﬁltering is grad-
ually increased and the signals from small molecules decay more
rapidly, according to Eq. (1):
ln I=Io ¼ Dð2=pÞ2G2c2d2ðD d=4Þ; ð1Þ
where I is the intensity, Io is the intensity when G = 0 G/cm, D is the
diffusion coefﬁcient (cm2 s–1), G is the strength of the applied gradi-
ent (G/cm), c is the proton gyromagnetic ratio, d is the time (s) that
the gradient ﬁeld pulse is active, and D is the time (s) between gra-
dient pulses to allow diffusion of the molecules.
The shape of the signal decay for each molecule is the same for
each resonance, although the accuracy of the ﬁtting will depend on
the relative intensity of the different resonances. For a good-qual-
ity DOSY spectrum, we aim at reducing the intensity of our protein
signals (Fig. 2, squares) by more than 90% when we apply the max-
imum gradient strength in the ﬁnal experiment (Fig. 2, gradi-
ent = 35 G/cm). Under the same conditions, the signals of small
molecules are generally reduced by more than 99% by the middle
of the experiment compared with a reduction of approximately
50% for the protein (Fig. 2, triangles, gradient 14 G/cm). Acquisi-
tion of a 1D DOSY spectrum corresponding to the middle gradient
increment of the 2D DOSY series results in a representative 1D 1H
spectrum of the protein where intensities of the signals of small
molecules have been greatly reduced relative to those of the pro-
tein; this is a well-established method to suppress solvent reso-
nances (Fig. 2, circles) [7–9]. Our aim to reliably pick up signals
from small molecules can be achieved by the comparison of 1D
DOSY spectra corresponding to the ﬁrst and middle spectra in
the 2D DOSY. The 1D DOSY difference spectrum enables an objec-
tive interpretation in contrast to the subjective interpretation of
the deﬂections present in the 2D DOSY spectrum (Fig. 1B). An addi-
tional advantage of collecting 1D spectra over 2D spectra is a sav-
ing of time or, alternatively, increasing the signal/noise ratio by
performing more scans per experiment.
Fig. 2 suggests that the optimal gradient strengths in 1D DOSY
experiments to differentiate between a low-molecular-weight
molecule (e.g., Tris) and a protein (e.g., the homodimeric hgal-1)
are gradient strengths of 0 and 14 G/cm. However, it is desirable
to use the shortest possible values of D and d in the DOSY experi-
ment to minimize relaxation losses during the diffusion delay, D.
Gradient strengths of 0 and 35 G/cm with D = 100 ms and
Fig. 3. 1D 1H (left panels) and 1D DOSY difference (right panels) spectra of samples of hgal-1 at a concentration of 110 lM: (A, B) after adding 20 lM Tris; (C, D) after adding
5 lM Tris; (E, F) after adding 1 lM Tris. The 1D DOSY difference spectra were recorded with the stebpgp1s1d sequence and no solvent suppression. All 1D 1H spectra were
acquired over 16 scans, and the 1D DOSY difference spectra were acquired over 2  1024 scans (1 h, panels B and D) and 2  2048 scans (2 h, panel F).
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D = 400 ms and d = 4 ms for protein analyses and the simulation
in Fig. 2). These modiﬁed conditions were used in 1D DOSY exper-
iments on samples of hgal-1 supplemented with low concentra-
tions of Tris buffer to simulate a buffer exchange scenario. 1D
DOSY provided detection of 1 lM Tris on a 600-MHz spectrometer
ﬁtted with a cryoprobe (Fig. 3), whereas 1D 1H NMR experiments
failed to detect the presence of Tris. These samples were preparedFig. 4. 1D 1H (left panels) and 1D DOSY difference (right panels) spectra of four prot
lactalbumin (14.4 kDa); (E, F) carbonic anhydrase (30 kDa); (G, H) BSA (66 kDa). The 1
difference is the result of two 1024-scan experiments (54 min). The imidazole signals ain deuterated buffer, and the experiments were performed without
applying solvent suppression.
Next, we tested the detection limit of the 1D DOSY difference
method in samples prepared in standard buffers (simply contain-
ing minimal concentrations of 2H2O to maintain the lock signal)
by adding imidazole to four proteins of different molecular weights
(Fig. 4). Aprotonin (6.6 kDa) produces very sharp resonances. As a
result, signals of imidazole can readily be hidden within theein standards with 30 lM imidazole added: (A, B) aprotonin (6.6 kDa); (C, D) a-
D 1H spectra were recorded in a 256-scan experiment (6 min), and the 1D DOSY
ppear at 7.4 and 8.2 ppm. For clarity, only the low-ﬁeld signals are shown.
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very broad resonances from which the sharp imidazole resonances
may prove to be visible in 1D 1H NMR spectra without resorting to
the 1D DOSY difference method. The other proteins tested were a-
lactalbumin (14.4 kDa) and carbonic anhydrase (29 kDa) of inter-
mediate size and properties. Overall, we found that the results
for all four proteins were similar. Two 1D DOSY spectra were ob-
tained with a total accumulation time of 54 min, and a detection
level of 30 lM imidazole was apparent for each of these proteins
(Fig. 4), based on titrations of 0, 10 20, 30, and 40 lM imidazole.
For comparison, the peaks for 30 lM imidazole could not be clearly
identiﬁed in the 1D 1H NMR spectra of any of these samples
(Fig. 4).
One reason for concern regarding the spectra presented so far is
that the samples contain 5–100% 2H2O. This represents a source of
sample contamination and/or manipulation to prepare the NMR
samples. The a-lactalbumin samples shown in Fig. 4C and D were
dissolved in 100% H2O solutions, and the 2H2O necessary for the
lock was presented in a coaxial insert. The insert did not compro-
mise the detection limits of the 1D DOSY difference experiment
(Fig. 4).
Standard 1D 1H NMR spectra are already useful when the small
molecule is in excess over the protein. For example, Fig. 5A and C,
and (to a lesser extent) 5E readily illustrate the presence of imidaz-
ole during the early stages of dialysis of His-tagged ubiquitin. The
imidazole peaks can be assigned with certainty by 1D 1H DOSY dif-
ference (Fig. 5H) while being undetectable by 1D 1H NMR (Fig. 5G)
for the same sample. To broaden the experimental basis, the 1D
DOSY difference spectra methodology was applied to two other
protein samples. DREAM is a calcium-binding protein with unique
DNA-regulating properties within the EF-hand family [25]. His-
tagged DREAM 71–256 was dialyzed after elution using 150 mM
imidazole. It forms an oligomeric molten globule structure [26],
and no sharp resonances are observed in its 1D 1H NMR spectrum.
After the last dialysis step (Fig. 5K and L), imidazole was detectable
in neither the 1D 1H NMR DOSY nor the 1D DOSY, meaning that
imidazole, if present, should be below a concentration level of
30 lM. FtsZ (40.2 kDa) is the bacterial homologue of tubulin
[19,27]. FtsZ was dialyzed from a 10% glycerol stock solution; com-
monly, glycerol is not easily removed by dialysis (Fig. 5M and N).
The sharp resonance at 3.7 ppm is due to the residual 1H signal
from the deuterated Tris buffer. Rather small peaks in the 3- to
4-ppm region originate from residual glycerol and ethylenedi-
aminetetraacetic acid (EDTA). For comparison, only the residual
Tris signal was detected in the 1D 1H NMR spectrum.Discussion
It was our aim to present a facile NMR protocol for tracking
down the presence of small molecules in protein samples. After
the optimization of several parameters for the 1D 1H DOSY pulse
program (see Materials and methods and Supplementary material
for details), we were able to detect substoichiometric concentra-
tions of small molecules in protein samples. To underscore a gen-
eral applicability, we tested a range of deﬁned samples as well as
chromatography eluates and their dialysates. Therefore, the pre-
sented NMR spectroscopy approach is revealed as a valuable tool
for assessing the level of low-molecular-weight compounds in pro-
tein preparations at concentrations typically found in fractions ob-
tained by elution during afﬁnity chromatography (1 mg/ml,
P10 lM). The method is of interest to protein crystallographers
as well as to those involved in a range of biochemical and pharma-
ceutical applications. 1D 1H NMR spectra, due to the large differ-
ences in transversal relaxation between low-molecular-weight
compounds (<1 kDa) and high-molecular-weight compounds(>10 kDa), can readily detect small molecules despite the broad
protein resonances when their concentration is higher than that
of the protein. As added value, 1D 1H DOSY difference comple-
ments the standard 1D 1H NMR experiment when the sample con-
tains small proteins (<100 kDa) with deﬁned resonances or when
the contaminants are present in a quantity below the protein con-
centration. One could envision 1D 1H difference spectra to improve
the detection limit for small molecules. However, this approach re-
quires the availability of the spectrum of a pure protein collected
under identical sample and spectrometer conditions. Because this
is difﬁcult to attain, any positive result will be subject to a degree
of uncertainty. Clearly, an advantage of the 1D DOSY difference
method is that it does not rely on a reference sample.
An inherent limitation of the 1D 1H NMR and 1D DOSY methods
is that the low-molecular-weight ligand or contaminant must con-
tain nonexchangeable 1H signals (inorganic salts such as phosphate
are not directly observable by 1H NMR). A second limitation is that
only free small molecules will be detected; any protein-associated
compound will share the same diffusion parameters of the protein.
Regarding equipment, our work was carried out on Bruker 500-
and 600-MHz instruments. Because the objective of 1D DOSY dif-
ference is to trace small molecules, it is likely that lower ﬁeld
strengths and analytical instruments used by chemists may be suf-
ﬁcient for this purpose, although detection limits might be com-
promised. Of note, we deliberately use a widely available pulse
program from the Bruker pulse sequence library to illustrate appli-
cability, acknowledging the possibility that other pulse sequences/
programs may provide spectra with improved signal/noise ratio
and detection limits for small molecules. The GraPES (gradient
phase encoded spin-lock) pulse sequence incorporates a spin-lock
to selectively remove protein signals so as to provide improved dis-
crimination between protein and small-molecule signals [13].
However, resonances from highly mobile loops of proteins or post-
translational modiﬁcations (i.e., in glycoproteins) may still appear
to mimic small-molecule signals [13]. Therefore, the use of the
GraPES pulse sequence in our protocol should provide two spectra
with a mildly reduced signal/noise ratio for small molecules (26%
reduction for the example in Ref. [13]) and a greatly reduced pro-
tein background. Residual protein resonances will be observed at
both high and low diffusion gradient strengths, whereas small-
molecule signals will be observed at only low diffusion gradient
strength. A control titration of imidazole into pure buffer, using
the stebpgp1s191d pulse program and the same parameters as
for the spectra shown in Fig. 4, yielded a detection limit of
10 lM as compared with 30 lM in the presence of 1 mg/ml protein
due to the complete absence of protein signals in this sample.
Therefore, a two- to threefold improvement in the detection limit
can be expected for the GraPES pulse sequences and other se-
quences that are as yet unavailable in distributed pulse program li-
braries. Finally, we have not collected data with equipment from
other NMR spectrometer manufacturers (e.g., Varian, Jeol) and
the pulse sequences/programs available to users of these instru-
ments. However, the protocol described here should also be easily
applicable to these instruments.
With our Bruker instruments, the detection limits are approxi-
mately 5–100 lM by 1D 1H NMR spectroscopy, depending on the
protein line widths, and 1–30 lM by 1D DOSY difference. The
improvement in the detection levels of the 1D DOSY difference
method is demonstrated in the test experiments with proteins of
different molecular weights (Fig. 4), reaching a limit of less than
30 lM imidazole in 1 h. At this stage, it should be noted that 1D
DOSY difference spectra are useful to qualitatively detect the pres-
ence of contaminants over a concentration offset of approximately
10–30 lM 1H equivalents. However, we have not fully imple-
mented DOSY to perform quantitative measurements of concentra-
tions. Although resonances of equal peak volume from two
Fig. 5. 1D 1H spectra (left panels) and 1D DOSY difference (right panels). (A, B) His-tagged ubiquitin eluted with buffer containing 150 mM imidazole. (C, D) His-tagged
ubiquitin after one step of dialysis. (E, F) His-tagged ubiquitin after the second step of dialysis. (G, H) His-tagged ubiquitin after the third step of dialysis. (I, J) His-tagged
ubiquitin after the fourth step of dialysis. (K, L) Present the ﬁnal spectra obtained for His-tagged DREAM 71–256 after extensive dialysis. (M, N) Document spectra of FtsZ after
dialysis and buffer exchange. The sharp peak at 3.9 ppm (both spectra) stems from residual protons in Tris–d11, and rather small peaks visible only in the 3- to 4-ppm section
of the 1D DOSY difference spectrum arise from glycerol and EDTA. All experiments were run at parameters identical to those given in the legend to Fig. 4.
122 Diffusion NMR and small molecules in protein / J.P. Ribeiro et al. / Anal. Biochem. 396 (2010) 117–123different molecules in a 1D 1H NMR experiment indicate equiva-
lent concentrations, this is not the case in the 1D DOSY difference
spectrum because relative diffusion properties need to be consid-
ered. To establish a quantitative protocol, we suggest the titration
of the small ligand into a solution of a pure protein at a concentra-
tion similar to that of the unknown samples (the pure protein ofinterest or a control protein of similar size). This titration can be
used as a calibration to determine the concentration of small mol-
ecules. The expected errors for such a quantitative analysis are ex-
pected to be high, and the process is time-consuming for a single
analysis. However, this approach may be valuable with respect to
routine quality control in a process environment. In summary,
Diffusion NMR and small molecules in protein / J.P. Ribeiro et al. / Anal. Biochem. 396 (2010) 117–123 1231D DOSY difference has been introduced as a method to detect the
presence of subequimolar concentrations of small-molecule con-
taminants in protein samples.
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